Atomized Inhalation ICG for Treatment of Congenital Lung Malformations
Recruiting now · Not applicable
Conditions studied: Pulmonary Sequestration, Congenital Pulmonary Airway Malformation, Indocyanine Green, Thoracoscopic Surgery, Children
In brief
To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children.
Key facts
- Study ID
- NCT06302985
- Run by
- Jiexiong Feng
- People needed
- 50
- Starts
- 2024-03-01
- Expected to finish
- 2050-12-31
- Last updated by the study team
- 2024-10-16
Who can join
Age: 0 and older, up to 14. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- children with congenital lung malformations diagnosed by CT or MRI scan
You may not qualify if…
- 1. ages <3 months and >14 years 2. complicated other life-threatening disease; 3. complicated severely pulmonary infection
Where it is running
- Tongji Hospital — Wuhan, Hubei, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.